Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Amatera logo — company profile

Amatera

Founded 2022 2-10 employees Pre-Seed Total: $1.60M Biotechnology

General Information

Company Name Amatera
Founded Year 2022
Employees 2-10
Industries Biotechnology
Funding Stage Pre-Seed
Social

BounceWatch is an independent company data service, not affiliated with Amatera. To contact Amatera, visit amatera.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Amatera compare?

A PDF of Amatera and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Amatera soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Amatera

Amatera is a biotechnology research company founded in 2022 by Omar Dekkiche and Lucie Kriegshauser, based in Paris, France. The company is dedicated to developing sustainable and climate-resilient coffee varieties to cater to the increasing demand. In a recent milestone, Amatera secured a €1.50M Pre Seed Round investment on 20 October 2023 from prominent investors including AgFunder, Joyance Partners, Mudcake, PINC, Exceptional Ventures, and Nicolas Morin-Forest. The company's focus on addressing the challenges of sustainability and climate change within the coffee industry aligns with the growing global demand for environmentally conscious products. Amatera's innovative approach to biotechnology in agriculture and its strategic location in Paris, a hub for biotech innovation, positions it as a potential disruptor in the market. The recent investment signals confidence from notable investors, indicating a strong potential for growth and impact within the biotechnology industry. With the support from these investors, Amatera is poised to make significant strides in advancing sustainable practices in coffee production, potentially carving a niche in the market and attracting further interest from the investment community.

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round €1.50M 6
AgFunder Joyance Partners Mudcake
AgFunder, Joyance Partners +4
20 Oct 2023
Pre Seed Round $100.00K 2
AgFunder GROW Agrifoodtech Accelerator
AgFunder, GROW Agrifoodtech Accelerator
03 May 2023
Non Equity Assistance Undisclosed 1
AGORANOV
AGORANOV
01 Feb 2023

Latest News

View All
The coffee disruptors: 10 European startups brewing the future of coffee — Eu-startups
The coffee disruptors: 10 European startups brewing the future of coffee
Eu-startups Aug 18, 2025

Amatera Alternatives & Competitors

View All Alternatives
Amatera vs
AFINGEN®
AFINGEN® United States

Designing the Next Generation of Crops

Grant
4 employees
Agriculture, Biotechnology
Amatera vs
Targeted Growth
Targeted Growth United States

Targeted Growth, Inc. (TGI) is a crop biotechnology company focused on developing products with enha...

Venture round
17 employees
Agriculture, Biotechnology
Amatera vs
Hudson River
Hudson River The Netherlands

Pioneers in the application of Protoplast-CRISPR technology for better, more resilient crops - at sc...

Venture round
22 employees
Biotechnology, Manufacturing
View all alternatives

FAQ About Amatera

Amatera is a pioneering biotechnology research company focused on developing coffee varieties with enhanced sustainability and climate resilience to meet growing demand. Established in 2022 by Omar Dekkiche and Lucie Kriegshauser, the company is based in Paris, France.
Amatera was founded in 2022.
Amatera operates in Biotechnology.
Amatera has approximately 2-10 employees.
Amatera has completed 3 funding rounds, raising a total of $1.60M. The latest funding stage is Pre-Seed.
Top alternatives and competitors to Amatera include AFINGEN®, Targeted Growth, Hudson River, Alderaan Biotechnology, Diatos. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Amatera and AFINGEN® are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Amatera, https://bouncewatch.com/company/amatera, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes